PRESS RELEASE 

Brings advanced cannabinoid formulations and delivery methods to world’s largest cannabis market

DENVER (DATE TK, 2018)– Next Frontier Biosciences, a Colorado-based cannabis drug development and commercialization firm, today announced a partnership with BAS Research to bring its Verra Wellness line of premium cannabis-infused products to the California medical and adult-use marijuana markets. The Verra Wellness line of sublingual sprays and topical salves are anticipated to be available in California by Q3 2018.

“Expanding into California allows Next Frontier Biosciences to tap into the state’s multibillion-dollar marijuana industry–gaining access to what is projected to be the world’s largest legal cannabis market,” said Marc Graboyes, Co-Founder and CEO of Next Frontier Biosciences. “Our cutting-edge Verra Wellness products are designed to meet the California market’s need for clean, consistent and trustworthy products that allow consumers the ability to manage their dose. Our partner, BAS Research, shares this vision for the industry’s future and we are excited to work together to pursue our mutual goal of providing consumers with best-in-class cannabis products that are safe, effective and discreet.”

BAS Research is a leading cannabis research and manufacturing company that provides a variety of services to clients, including compliance, product development, formulation, extraction, contract manufacturing, and fulfillment. Founded by veterans of the cannabis, pharmaceutical and technology industries, the company manufactures high-quality cannabis products with a focus on superior innovation, integrity and socially responsible production processes–mirroring Next Frontier’s own structure and values.

“Drawing upon our pharmaceutical industry background, we have established a robust technology transfer process to allow for the rapid scale up and commercialization of our Verra Wellness products in other legal state marijuana markets,” continued Mr. Graboyes. “Our licensing business model supports a global expansion strategy and we are actively seeking strategic partners with the licenses and facilities required to manufacture and distribute our products in their respective state markets. With the industry poised for continued growth, we look forward to establishing a global brand of trusted cannabis products that offer unparalleled quality and consistency.”

Founded in 2014, Next Frontier Biosciences has assembled a team of highly experienced biotech executives and research scientists with over 100 years of pharmaceutical drug development experience. The company employs a traditional scientific approach to product development that includes advanced purification, analytical and chemical formulation methods. Next Frontier Biosciences’ proprietary formulations were carefully developed and optimized for improved delivery via nasal, sublingual and topical administration with a focus on providing unparalleled quality, consistency and reproducibility.

About Next Frontier Biosciences:

At Next Frontier Biosciences, we believethat cannabinoid purification and scientific formulation are the keys to unlocking the power of the plant and developing safer and more effective cannabinoid-based products. Scientifically formulated to provide accurate dosing, improved bioavailability and optimized cannabinoid profiles, our Verra Wellness line of products, including nasal mists, sublingual sprays and topical salves, offer fast acting and consistent results. Additionally, their unique modes of administration are discreet and effective, providing both medical and adult-use cannabis users with desirable alternatives to smoking, vaporizing or eating cannabis-infused products. At Next Frontier Biosciences, we maintain an unyielding commitment to scientific excellence and integrity, so our products aren’t just created from cannabis—they’re derived from truth.

Forward-Looking Statements:

To the extent any statements made in this press release contain information that is not historical, these statements are forward-looking in nature and merely express our beliefs, expectations or opinions. For example, words such as “may,” “should,” “estimates,” “predicts,” “continues,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “potential,” “strategy” and similar expressions are intended to identify forward-looking statements. Such statements are based on current expectations or estimates and involve a number of known and unknown risks and uncertainties that could cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, the following: (i) our ability to implement our business strategy of distributing high quality cannabis products where permissible under applicable law; (ii) availability and cost of additional capital; (iii) our ability to attract, retain and motivate qualified employees and management; (iv) the impact of federal, state or local government regulations; (v) competition in the cannabis industry; (vi) our ability to generate revenues; and (vii) litigation in connection with our business. All forward-looking statements included in this press release and attributable to us or any person acting on our behalf are qualified by this cautionary statement. Forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation to update or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise.

###

For more information on Next Frontier Biosciences and/or Verra Wellness or to schedule an interview, please contact Dorothy Colagiovanni at 720-261-2879 or [email protected].

For more information, visit http://nextfrontierbio.com/. Follow us onFacebook,Twitter,Instagram and LinkedIn.